O'Donnell's Drug Injury

James J. O'Donnell III, M.S., Ph.D., is a chemist and research pharmacologist. He is an Associate Professor at Rosalind Franklin University of Medicine and Science, where he teaches at the Chicago Medical School and the College of Pharmacy. He is the pharmacology coordinator at the Chicago Medical School, and in the College of Pharmacy he was the founding course director of the core pharmacology courses as well as a forensic toxicology and pharmacology elective. He has also given guest lectures at Rush University on pharmacokinetics and other pharmacology topics. He served as an NIH T32 Training Grant Postdoctoral Fellow in Respiratory Biology at the University of Chicago. He has also held a postdoctoral appointment at the Indiana University School of Medicine at South Bend. His research has primarily focused on inflammatory diseases and pharmacokinetics. He has conducted organometallic chemistry research at University of Wisconsin-Madison and at Northwestern University in Evanston, IL. He currently serves as President of the American Society for Pharmacology and Experimental Therapeutics - Great Lakes Chapter (ASPET-GLC) and is a member of the American College of Clinical Pharmacology (AACP) and the American Academy of Clinical Toxicology (AACT). He is a Co-Editor of O'Donnell's Drug Injury, Fourth Edition, and the Chief Editor of Drug Discovery and Development, Third Edition. He consults in drug injury, analytical toxicology, and other related matters. Dr. O'Donnell received a Bachelor of Science Degree in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology (MIT), a Master of Science Degree in Chemistry from the University of Wisconsin-Madison, and a Doctor of Philosophy in Pharmacology from Rush University in Chicago, IL.

James T. O'Donnell, Pharm.D., M.S., FCP, ABCP, FACN, is a pharmacologist, pharmacist, and nutritionist in Barrington Hills, Illinois. He is an Associate Professor of Pharmacology at Rush University Medical Center in Chicago, IL where he served as the Course Director of the Medical Pharmacology course. He also held faculty appointments at the University of Illinois Colleges of Medicine and Pharmacy. Dr. O'Donnell is a Diplomate of the American Board of Clinical Pharmacology, a Fellow of the American College of Clinical Pharmacology, a Fellow of the American College of Nutrition, Founding Editor-in-Chief of the Journal of Pharmacy Practice, and Editor of Drug Injury: Liability, Analysis, and Prevention, First Edition, Second Edition, Third Edition; Co-Editor of O'Donnell's Drug Injury, Fourth Edition, a Co-Editor of Pharmacy Law: Litigating Pharmaceutical Cases, and Co-Editor of Drug Discovery and Development, Second and Third Editions. He consults and testifies in matters involving pharmaceuticals, medication errors, nutritionals, dietary supplements, alcohol and recreational drug toxicity, and drug injuries throughout the United States, for defense and plaintiffs' counsel. Dr. O'Donnell received a Bachelor of Science in Pharmacy from the University of Illinois, a Doctor of Pharmacy from the University of Michigan, and a Master of Science in Clinical Nutrition from Rush University.

Gourang Patel, Pharm.D., M.Sc., BCPS, BCCCP, FCCP, FCCM, is the Director of Clinical Pharmacy Services at the University of Chicago Medicine - Chicago, IL. Dr. Patel earned a Bachelor of Chemistry from Truman State University, Doctorate in Pharmacy from the St. Louis College of Pharmacy, and his Masters in Clinical Research from the Rush Graduate College. He also reviews medical malpractice cases for both Defense and Plaintiff sides in the areas of pharmacology, toxicology, and pharmacy practices. Dr. Patel is dual board certified in Pharmacotherapy (BCPS) and Critical Care (BCCCP) and is a Fellow within the American College of Clinical Pharmacy (FCCP) and within the Society of Critical Care Medicine (FCCM).

Jennifer Splawski, Pharm.D., M.S., BCPS, is currently a Director of Clinical Value at BluesightTM, A Medication Intelligence Company, where she leads clients in creating successful controlled substance diversion programs incorporating artificial intelligence-based software. Her experience includes clinical pharmacy practice specializing in emergency medicine, operational leadership, and implementing technology within the healthcare space. She also consults and testifies on legal matters for both Defense and Plaintiff cases related to medication errors and clinical pharmacology/toxicology throughout the United States. Dr. Splawski earned a Bachelor of Science in Psychology and Doctor of Pharmacy degree from the University of Illinois at Chicago, and a Master of Science degree in Pharmacy focusing in Clinical Toxicology and a Forensic Toxicology Certificate from the University of Florida. She served a postgraduate Pharmacy Residency at the University of California in San Francisco and is a Board-Certified Clinical Pharmacy Specialist (BCPS).